Clinical Perspectives

Cysview Blue Light Cystoscopy Technology for Bladder Cancer Available at Moffitt Cancer Center

A new imaging technology, called Cysview Blue Light Cystoscopy (BLC), can be used to help bladder cancer surgeons to better detect and remove as many...

Top Treatment Developments in Cancer Care

Moffitt’s notable breakthroughs include advancements in fluorescent imaging, personalized medicine through mathematics and a better understanding of...

Top 5 Misconceptions About Referring Patients to Moffitt

Practitioners can refer patients directly to Moffitt for prevention, screenings, and diagnosis services as well as cancer care, but common...

Q&A: Dr. McMullen Receives National Recognition as AWS 40 Under 40 Female Surgeons

Dr. Caitlin McMullen, a surgeon in the Department of Head and Neck-Endocrine was recognized as 40 Under 40 Female Surgeons by the Association of...

Minimally Invasive Surgery Approach for Paraspinal Lumbar Schwannomas

Schwannomas are benign tumors that arise from Schwann cells that surround peripheral nerves. Learn more about surgery options.

What You Need to Know About Minimally Invasive Surgery for Gynecologic Cancers

Moffitt’s cancer care teams include surgeons who specialize in minimally invasive surgeries (MIS) utilizing robotic surgical systems for a variety of...

Distant Margins Following Pelvic Exenteration Improve the Survival Rate for Women with Gynecologic Cancer

A study shows patients with distant margins following pelvic exenteration have improved the overall survival rate by 111 months when compared to...

Q&A with Dr. Michael Vogelbaum on Stereotactic Radiosurgery for Brain Tumors

Stereotactic radiosurgery is a non-invasive treatment that is delivered with the highest precision, like a neurosurgical procedure, but without an...

Gynecologic Cancer Genetics and Molecular Medicine Tumor Board at Moffitt Cancer Center

We offer a highly collaborative Gynecologic Cancer Genetics and Molecular Medicine Tumor Board to ensure that each patient is provided with a...

Q&A: Dr. Alice Yu Discusses Management of Localized Prostate Cancer Using Irreversible Electroporation Ablation

Moffitt's Dr. Alice Yu discusses the different treatment options for localized prostate cancer, including focal therapy, an FDA-approved treatment.

Q&A: Dr. Yamoah Shares His Vision for Moffitt To Become Global Epicenter for Precision Radiotherapy

The new chair of the Department of Radiation Oncology, Dr. Kosj Yamoah, shares his vision for the department and hopes for Moffitt to be the leader...

Fluorescent Imaging Technology Now Available At Moffitt For Ovarian Cancer Surgery

The U.S. Food and Drug Administration (FDA) recently approved CYTALUX for adult patients with ovarian cancer as an adjunct for intraoperative...

Some Cancer Symptoms More Likely to Present in Emergency Rooms

Emergency room providers are increasingly diagnosing cancer symptoms in patients. It is important that ER providers refer these patients to a cancer...

Understanding Chronic Myelogenous Leukemia (CML)

Chronic myeloid leukemia often doesn’t produce noticeable symptoms in its early stages. In fact, many patients don’t realize there is a problem until...

Refining Multiple Myeloma Treatments: the EMMA Created at Moffitt

A result of Mark Pentecost’s generous donation, the EMMA database tests a multiple myeloma patient’s sensitivity to dozens of drugs at one time to...